Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-27

Clinical Trial Update: Treating Schizophrenia by Correcting Abnormal Brain Development [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial led by Beth Israel Deaconess Medical Center is investigating a treatment for schizophrenia that aims to correct abnormal brain developm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Schizophrenia | Phase 3 | Status: ACTIVE_NOT_RECRUITING